488 related articles for article (PubMed ID: 16950975)
1. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.
Grijalva CG; Poehling KA; Nuorti JP; Zhu Y; Martin SW; Edwards KM; Griffin MR
Pediatrics; 2006 Sep; 118(3):865-73. PubMed ID: 16950975
[TBL] [Abstract][Full Text] [Related]
2. Population-based impact of pneumococcal conjugate vaccine in young children.
Poehling KA; Lafleur BJ; Szilagyi PG; Edwards KM; Mitchel E; Barth R; Schwartz B; Griffin MR
Pediatrics; 2004 Sep; 114(3):755-61. PubMed ID: 15342850
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
[TBL] [Abstract][Full Text] [Related]
4. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.
Zhou F; Shefer A; Kong Y; Nuorti JP
Pediatrics; 2008 Feb; 121(2):253-60. PubMed ID: 18245415
[TBL] [Abstract][Full Text] [Related]
5. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.
Poehling KA; Szilagyi PG; Grijalva CG; Martin SW; LaFleur B; Mitchel E; Barth RD; Nuorti JP; Griffin MR
Pediatrics; 2007 Apr; 119(4):707-15. PubMed ID: 17403841
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
9. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
Zhou F; Kyaw MH; Shefer A; Winston CA; Nuorti JP
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1162-8. PubMed ID: 18056561
[TBL] [Abstract][Full Text] [Related]
10. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
Garbutt J; Rosenbloom I; Wu J; Storch GA
Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.
Ray GT; Pelton SI; Klugman KP; Strutton DR; Moore MR
Vaccine; 2009 Nov; 27(47):6483-94. PubMed ID: 19720366
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
13. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.
Grijalva CG; Griffin MR
Expert Rev Vaccines; 2008 Feb; 7(1):83-95. PubMed ID: 18251696
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
[TBL] [Abstract][Full Text] [Related]
16. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.
Jardine A; Menzies RI; Deeks SL; Patel MS; McIntyre PB
Pediatr Infect Dis J; 2009 Sep; 28(9):761-5. PubMed ID: 19546840
[TBL] [Abstract][Full Text] [Related]
17. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
[TBL] [Abstract][Full Text] [Related]
18. [Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].
de Arístegui Fernández J; Corretger Rauet JM; García Martín F; Hernández-Sampelayo T; Moraga Llop FA; Rodrigo Gonzalo De Liria C; Ruiz Contreras J;
An Esp Pediatr; 2002 Jan; 56(1):79-90. PubMed ID: 11792258
[TBL] [Abstract][Full Text] [Related]
19. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States.
Zhou X; de Luise C; Gaffney M; Burt CW; Scott DA; Gatto N; Center KJ
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():96-102. PubMed ID: 30690309
[TBL] [Abstract][Full Text] [Related]
20. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
